论文部分内容阅读
目的观察子宫动脉栓塞术联合子宫切口妊娠病灶清除术治疗子宫切口妊娠患者的效果。方法将医院2013年1月-2015年1月接收的子宫切口妊娠患者79例随机分为治疗组40例与对照组39例,其中对照组行子宫切口妊娠病灶清除术,治疗组在对照组基础上联合应用子宫动脉栓塞术治疗。观察2组治疗前后血清人绒毛膜促性腺激素(β-HCG)水平,对比2组β-HCG恢复正常的时间、手术时间及术中出血量、住院时间。结果 2组治疗前β-HCG水平比较无统计学差异(P>0.05),治疗后2组患者的β-HCG均高于治疗前,且治疗组高于对照组,差异均有统计学意义(P<0.05);治疗组患者的β-HCG水平恢复正常时间、手术时间、住院时间均明显短于对照组,术中出血量少于对照组,差异均有统计学意义(P<0.05)。结论子宫动脉栓塞术联合子宫切口妊娠病灶清除术治疗子宫切口妊娠患者疗效显著,不仅可缩短β-HCG恢复正常的时间,且术中出血量小、手术时间更短,值得临床应用与推广。
Objective To observe the effect of uterine artery embolization combined with uterine incision pregnancy debridement in the treatment of uterine incision pregnancy. Methods 79 cases of uterine incision pregnancy received by the hospital between January 2013 and January 2015 were randomly divided into treatment group (40 cases) and control group (39 cases), in which the control group was treated with uterine incision pregnancy debridement. The treatment group was basal in the control group On the joint application of uterine artery embolization. The levels of serum human chorionic gonadotropin (β-HCG) before and after treatment were compared between the two groups. The time of returning to normal, the operation time, intraoperative blood loss and hospital stay were compared. Results There was no significant difference in β-HCG level between the two groups before treatment (P> 0.05). The β-HCG level of the two groups after treatment was higher than that before treatment, and the treatment group was higher than the control group (P> 0.05) P <0.05). The level of β-HCG in treatment group returned to normal, operation time and hospitalization time were significantly shorter than those in control group. The blood loss in operation group was less than that in control group. The difference was statistically significant (P <0.05). Conclusion Uterine artery embolization combined with uterine incision pregnancy removal of the treatment of uterine incision pregnancy patients with significant effect, not only can shorten the recovery time of β-HCG, and less blood loss, shorter operative time, it is worthy of clinical application and promotion.